Pfizer to invest $1.26 billion in Belgium plant in European expansion plan
Pfizer Inc. plans to invest 1.2 billion euros (($1.26 billion) in its plant in Belgium over the next three years to expand in.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Pfizer Inc. plans to invest 1.2 billion euros (($1.26 billion) in its plant in Belgium over the next three years to expand in.
The Covid-19 virus, in some of the British patients discharged from hospitals, has led to lung damage which is irreversible and may get.
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.
India’s drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the world’s first intra-nasal vaccine.
Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.
AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million
The FDA is probing a drug, Prolia, used for the treatment of advanced kidney disease after initial investigations showed “a substantial risk with.
Baxter International has pulled the plug on its hospital bed systems in a recall termed by the FDA as “most serious” as the.
Biovac, a South Africa-based biotechnology company, has signed a technology transfer agreement with a South Korean institute to make an oral cholera vaccine.
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com